L-Asparaginase Injection
Generic Name |
L-Asparaginase |
---|---|
Strength |
10000 IU, 5000 IU, 3750 IU / 5 mL |
Form |
Injection |
Packaging |
Vials |
Therapeutic use |
Anti Cancer |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
L-Asparaginase Injection | 10000 IU, 5000 IU, 3750 IU / 5 mL | Anti Cancer |
Product Description For L-Asparaginase Injection
products details and uses
L-Asparaginase Injection Global Supplier, Manufacturer and Exporter India
L-Asparaginase Injection Global Supplier, as a trusted we focus on delivering safe, potent, and consistent injectable solutions that meet stringent quality norms and therapeutic requirements. Looking for a reliable L-Asparaginase Injection Global Supplier? Our company provides high-quality L-Asparaginase injections manufactured to international standards, offering effective treatment for acute lymphoblastic leukemia (ALL) and other hematologic malignancies.
Product Overview
L-Asparaginase is an enzyme-based injectable medication used primarily in the treatment of acute lymphoblastic leukemia. It works by depleting the amino acid L-asparagine in the bloodstream, which leukemia cells rely on for growth and survival. This mechanism selectively targets malignant cells while sparing normal cells, making it a critical component of combination chemotherapy regimens. Available in injectable form, L-Asparaginase ensures rapid bioavailability and consistent therapeutic effect. Our company, as a certified L-Asparaginase Injection Global Supplier, ensures each batch undergoes rigorous quality control and Good Manufacturing Practices (GMP) compliance, guaranteeing purity, stability, and potency.
Uses
L-Asparaginase injection is widely used for the treatment of:
-
Acute lymphoblastic leukemia (ALL) – as part of multi-agent chemotherapy protocols
-
Acute myeloid leukemia (AML) – in selected cases, particularly for pediatric patients
-
Lymphoblastic lymphoma – helping reduce malignant cell proliferation
-
Combination therapy – administered alongside other chemotherapeutic agents to improve efficacy and survival outcomes
Sourcing from a trusted L-Asparaginase Injection Global Supplier ensures that hospitals, oncology centers, and clinics have access to high-quality injectable formulations that support optimal patient care.
Precautions
Before administering L-Asparaginase injection, patients should undergo a thorough evaluation, and their medical history should be reviewed. Key precautions include:
-
Informing the physician about any history of allergies, pancreatitis, liver or kidney disorders
-
Monitoring for hypersensitivity reactions, as some patients may develop severe allergic responses
-
Regular assessment of liver function, blood clotting parameters, and pancreatic enzymes during therapy
-
Avoiding co-administration with medications that may increase the risk of bleeding
-
Ensuring proper hydration and nutritional support for pediatric and adult patients undergoing prolonged therapy
Side Effects
L-Asparaginase injections are generally well-tolerated but may cause mild to moderate side effects, including:
-
Nausea, vomiting, or abdominal discomfort
-
Fever or fatigue
-
Allergic reactions, including rash, itching, or, in rare cases, anaphylaxis
-
Liver enzyme elevation or pancreatitis
-
Blood clotting abnormalities, including bleeding or thrombosis
Using injections from a certified L-Asparaginase Injection Global Supplier helps minimize risks, as high-quality products undergo stringent testing to ensure safety, stability, and therapeutic efficacy.
Why Choose Us as Your L-Asparaginase Injection Global Supplier
As a leading L-Asparaginase Injection Global Supplier, we focus on providing safe, effective, and globally compliant injectable medications. Our state-of-the-art manufacturing facilities adhere to international quality standards, and every batch undergoes strict quality assurance testing. Oncology centers, hospitals, and pharmacies can rely on our L-Asparaginase injections to provide consistent therapeutic outcomes and support optimal leukemia management worldwide.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export L-Asparaginase Injection to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.